Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
46
datasets available to search
ShareScore release 0.9.0
Dataset results
46 results for “First-line Regimen”
SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC
ClinicalTrials.gov study NCT05438108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of H
ClinicalTrials.gov study NCT03386838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05160896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
ClinicalTrials.gov study NCT03511183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT05024812. IPD Sharing: NO. Countries: 1. Publications: 0.
P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens
ClinicalTrials.gov study NCT02533323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
ClinicalTrials.gov study NCT06254690. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
ClinicalTrials.gov study NCT06786312. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT07110064. IPD Sharing: NO. Countries: 1. Publications: 0.
Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Contro
ClinicalTrials.gov study NCT06946849. IPD Sharing: NO. Countries: 1. Publications: 0.
Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03286738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT06641544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study
ClinicalTrials.gov study NCT06770296. IPD Sharing: NO. Countries: 1. Publications: 0.
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
ClinicalTrials.gov study NCT06650332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen
ClinicalTrials.gov study NCT04191343. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen
ClinicalTrials.gov study NCT06123494. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients
ClinicalTrials.gov study NCT06313970. IPD Sharing: NO. Countries: 1. Publications: 0.
Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors
ClinicalTrials.gov study NCT05291052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients
ClinicalTrials.gov study NCT03869294. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)
ClinicalTrials.gov study NCT06454266. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.